Maryland-based Emergent BioSolutions Inc. (NYSE: EBS) will spin out cancer research group Aptevo Therapeutics into its own publicly traded company to be based in Seattle, the company announced this week. The tax-free spinoff will happen in mid 2016, the company said.
{iframe}http://www.bizjournals.com/baltimore/news/2015/12/23/maryland-company-to-spin-out-new-publicly-traded.html?ana=e_bal_rdup&s=newsletter&ed=2015-12-24&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1450962008{/iframe}